74 related articles for article (PubMed ID: 18726261)
21. Special Education.
Kozutsumi H
Oncologist; 1996; 1(1 & 2):116-118. PubMed ID: 10387976
[TBL] [Abstract][Full Text] [Related]
22. Thrombopoietin directly and potently stimulates multilineage growth and progenitor cell expansion from primitive (CD34+ CD38-) human bone marrow progenitor cells: distinct and key interactions with the ligands for c-kit and flt3, and inhibitory effects of TGF-beta and TNF-alpha.
Ramsfjell V; Borge OJ; Cui L; Jacobsen SE
J Immunol; 1997 Jun; 158(11):5169-77. PubMed ID: 9164933
[TBL] [Abstract][Full Text] [Related]
23. [Significance of thrombopoietin and its receptor c-Mpl in regulation of thrombocytopoiesis in thrombocytopenia].
Strauss G; Ballmaier M; Schulze H; Bogenberger J; Riehm H; Welte K
Klin Padiatr; 1996; 208(4):168-71. PubMed ID: 8926683
[TBL] [Abstract][Full Text] [Related]
24. Thrombopoietin supports in vitro erythroid differentiation via its specific receptor c-Mpl in a human leukemia cell line.
Yamada M; Komatsu N; Kirito K; Kashii Y; Tomizuka H; Okada K; Endo T; Fukumaki Y; Shinjo K; Abe K; Miura Y
Cell Growth Differ; 1998 Jun; 9(6):487-96. PubMed ID: 9663467
[TBL] [Abstract][Full Text] [Related]
25. Thrombopoietin: its role from early hematopoiesis to platelet production.
Wendling F
Haematologica; 1999 Feb; 84(2):158-66. PubMed ID: 10091415
[TBL] [Abstract][Full Text] [Related]
26. The synergistic effect of thrombopoietin in erythropoiesis with erythropoietin and/or IL-3 and myelopoiesis with G-CSF or IL-3 from umbilical cord blood cells of full-term neonates.
Liang DC; Shih LY; Kuo MC; Chai IJ; Su TH; Chen SH; Liu HC; Shimosaka A
Pediatr Hematol Oncol; 2001 Sep; 18(6):383-91. PubMed ID: 11554233
[TBL] [Abstract][Full Text] [Related]
27. Thrombopoietin is synergistic with other cytokines for expansion of cord blood progenitor cells.
Won JH; Cho SD; Park SK; Lee GT; Baick SH; Suh WS; Hong DS; Park HS
J Hematother Stem Cell Res; 2000 Aug; 9(4):465-73. PubMed ID: 10982244
[TBL] [Abstract][Full Text] [Related]
28. Megakaryocytopoietic activity of a truncated variant of mouse thrombopoietin.
Hoshi S; Yoshitomi H; Komatsu N; Yoshitake S; Okada M
Biochem Biophys Res Commun; 1997 Feb; 231(3):823-6. PubMed ID: 9070902
[TBL] [Abstract][Full Text] [Related]
29. [Congenital amegakaryocytic thrombocytopenia (CAMT) - a defect of the thrombopoietin receptor c-Mpl].
Germeshausen M; Schulze H; Gaudig A; Krukemeier S; Strauss G; Welte K; Ballmaier M
Klin Padiatr; 2001; 213(4):155-61. PubMed ID: 11528548
[TBL] [Abstract][Full Text] [Related]
30. Hematopoietic deficiencies in c-mpl and TPO knockout mice.
Murone M; Carpenter DA; de Sauvage FJ
Stem Cells; 1998; 16(1):1-6. PubMed ID: 9474742
[TBL] [Abstract][Full Text] [Related]
31. Physician Education: The Erythropoietin Receptor and Signal Transduction.
Yoshimura A; Arai K
Oncologist; 1996; 1(5):337-339. PubMed ID: 10388012
[TBL] [Abstract][Full Text] [Related]
32. [Expression of TPO mimetic peptide chimeric proteins with human IgG1 Fc fragments and their biological characters].
Li YX; Li C; Tao KH; Jia XH; Cheng DS; Huang PT
Sheng Wu Gong Cheng Xue Bao; 2002 Jul; 18(4):424-30. PubMed ID: 12385237
[TBL] [Abstract][Full Text] [Related]
33. [Thrombopoietin is a multifunctional factor].
Hino M
Rinsho Byori; 1997 Oct; 45(10):921-6. PubMed ID: 9369068
[TBL] [Abstract][Full Text] [Related]
34. Serum thrombopoietin level is not regulated by transcription but by the total counts of both megakaryocytes and platelets during thrombocytopenia and thrombocytosis.
Nagata Y; Shozaki Y; Nagahisa H; Nagasawa T; Abe T; Todokoro K
Thromb Haemost; 1997 May; 77(5):808-14. PubMed ID: 9184382
[TBL] [Abstract][Full Text] [Related]
35. Interleukin-3/erythropoietin fusion proteins: in vitro effects on hematopoietic cells.
Weich NS; Tullai J; Guido E; McMahon M; Jolliffe LK; Lopez AF; Vadas MA; Lowry PA; Quesenberry PJ; Rosen J
Exp Hematol; 1993 May; 21(5):647-55. PubMed ID: 8513865
[TBL] [Abstract][Full Text] [Related]
36. [Clinical use of thrombopoietin (c-Mpl Ligand)].
Borota R; Borota J; Belić A; Gebauer E; Stefanović N
Med Pregl; 1998; 51(11-12):501-8. PubMed ID: 10081270
[TBL] [Abstract][Full Text] [Related]
37. [Advances in research on cytokine mimetic peptides/non-peptides stimulating hematopoiesis].
Yuan ZH; Xi YZ; Kong FH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2002 Feb; 10(1):73-6. PubMed ID: 12513843
[TBL] [Abstract][Full Text] [Related]
38. Effect of human thrombopoietin-modified bone marrow mesenchymal stem cells mediated by recombinant adeno-associated virus on megakaryocytopoiesis.
Zhou XY; Tan MQ
Stem Cells Dev; 2007 Apr; 16(2):243-52. PubMed ID: 17521236
[TBL] [Abstract][Full Text] [Related]
39. Simultaneous administration of TPO and G-CSF after cytoreductive treatment of rhesus monkeys prevents thrombocytopenia, accelerates platelet and red cell reconstitution, alleviates neutropenia, and promotes the recovery of immature bone marrow cells.
Neelis KJ; Dubbelman YD; Qingliang L; Thomas GR; Eaton DL; Wagemaker G
Exp Hematol; 1997 Sep; 25(10):1084-93. PubMed ID: 9293906
[TBL] [Abstract][Full Text] [Related]
40. Thrombopoietin induces tyrosine phosphorylation and activation of mitogen-activated protein kinases in a human thrombopoietin-dependent cell line.
Yamada M; Komatsu N; Okada K; Kato T; Miyazaki H; Miura Y
Biochem Biophys Res Commun; 1995 Dec; 217(1):230-7. PubMed ID: 8526916
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
